IL17A and systemic lupus erythematosus: Preclinical studies that have hinted at involvement of IL-17A in SLE pathology indicate that the absence of IL-17 in experimental lupus models is associated with inhibition of autoantibody formation targeting DNA, RNP, and chromatin and, even more striking, lupus nephritis [62, 63].